US Patent 7541362 Heterocyclic dihydropyrimidine compounds
Patent 7541362 was granted and assigned to Bristol-Myers Squibb on June, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7541362 Heterocyclic dihydropyrimidine compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
